Biomechanics and regenerative medicine for a one-shot treatment
BRAVꓱ aims to provide a lifelong functional support to ischemic heartdisease (IHD) patients. The project will combine computational analysis, 3D printing and regenerative medicine to develop a biological ventricularassist device (BioVAD) to improve the patient’s quality of life.
The project gathers partners from different disciplines with the goal of bringing the medical advances close to the bedside in the shortest time possible. With this in mind, the BioVAD will be tested in pigs, as the heart of this animal model is the most similar to the human one.
Last news
BRAVƎ partners joined at the 5th General Meeting in Wurzburg
BRAVƎ consortium general meeting in Würzburg, Germany October 2024, Würzburg (Germany). The BRAVƎ project held its Annual Meeting 2024 the 29th and 30th of [...]
BRAVƎ Project Showcase Cutting-Edge Research on Biomaterials at International Congress in Fukuoka, Japan
BRAVƎ consortium present at Biofrabication 2024, Fukuoka, Japan November 2024. Some partners from BRAVƎ have participated in the prestigious International Congress on Biomaterials (https://www.biofabrication2024.org/) [...]
BRAVƎ has been extended for Six More Months to Deepen Insights and Enhance Results
The European Commission has granted a six-month extension to BRAVƎ October 2024, Pamplona (Spain). The European Commission has approved a six-month extension to the [...]